Creatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy

Bozbay M., Uyarel H., Avsar S., Oz A., Keskin M., Tanik V. O., ...More

JOURNAL OF CRITICAL CARE, vol.30, no.6, pp.1179-1183, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 6
  • Publication Date: 2015
  • Doi Number: 10.1016/j.jcrc.2015.07.014
  • Journal Name: JOURNAL OF CRITICAL CARE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1179-1183
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Background: Creatinine kinase isoenzyme-MB(CK-MB) is a biomarker for detecting myocardial injury. The aim of this study was to evaluate the association between admission CK-MB levels and in-hospital and long-term clinical outcomes in pulmonary embolism(PE) patients treated with thrombolytic tissue-plasminogen activator.